Polynovo Ltd CALZF:OTCPK

*Data is delayed | Exchange | USD
Last | 10:49 AM EDT
1.48quote price arrow up+0.06 (+4.23%)
Volume
1,000
52 week range
0.40 - 1.54
Loading...
  • Open1.48
  • Day High1.48
  • Day Low1.48
  • Prev Close1.42
  • 52 Week High1.54
  • 52 Week High Date03/14/24
  • 52 Week Low0.40
  • 52 Week Low Date09/01/23

Key Stats

  • Market Cap959.04M
  • Shares Out690.23M
  • 10 Day Average Volume5,350
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change85

KEY STATS

  • Open1.48
  • Day High1.48
  • Day Low1.48
  • Prev Close1.42
  • 52 Week High1.54
  • 52 Week High Date03/14/24
  • 52 Week Low0.40
  • 52 Week Low Date09/01/23
  • Market Cap959.04M
  • Shares Out690.23M
  • 10 Day Average Volume5,350
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change85

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)928.48
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Polynovo Ltd

 

Content From Our Affiliates

Profile

MORE
PolyNovo Limited is an Australia-based company, which is engaged in the development of medical devices for various medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM product is designed to help surgeons treat traumatic wounds. NovoSorb BTM may be used to temporarily close the wound and aid the body in generating new tissue. It is indicated for...
David Williams
Non-Executive Independent Chairman of the Board
Swami Raote
Chief Executive Officer
Jan Gielen
Chief Financial Officer, Company Secretary
David McQuillan Ph.D.
Chief Technical and Scientific Officer
Philip Scorgie
Chief Information Officer
Address
2/320 Lorimer Street
Melbourne, VIC
3207
Australia